project id: TCGA-HNSC; case submitter id: TCGA-QK-A64Z; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.88; rna integrity number: 8.2; age at index: 79; days to birth: -29037; days to death: 641; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1932; age at diagnosis: 29037; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage II; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T4; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 553.0; icd 10 code: C04.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Hard palate; synchronous malignancy: No; tissue or organ of origin: Hard palate; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Yes; is ffpe: false; composition: Not Reported; days to collection: 555; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-QK-A64Z-01A-11; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 70.0; percent tumor nuclei: 75.0;